TFS Capital’s Zimmer Biomet ZBH Stock Holding History

TFS Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,061	Closed	-$481K	–	785
2017 Q1	$481K	Sell	4,061 -641	-14%	-$72.7K	0.16%	200
2016 Q4	$471K	Buy	+4,702	New	+$504K	0.13%	264

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TFS Capital's ZBH Position: Q2 2017 in Review

TFS Capital sold out of Zimmer Biomet (ZBH) in Q2 2017, closing a stake of 4,061 shares — an estimated $481K sold.

TFS Capital first reported a position in ZBH in Q4 2016 and held it in 2 quarters. The position peaked at $481K in Q1 2017. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

TFS Capital reported no remaining Zimmer Biomet position as of Q2 2017 after selling out during the quarter.
TFS Capital sold 4,061 Zimmer Biomet shares in Q2 2017, an estimated $481K.
TFS Capital first reported a position in Zimmer Biomet in Q4 2016 and held it in 2 quarters.
TFS Capital's Zimmer Biomet position peaked at $481K in Q1 2017.
819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.